These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23706040)

  • 1. Is metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome?
    Lohith TG; Osterweil EK; Fujita M; Jenko KJ; Bear MF; Innis RB
    Mol Autism; 2013 May; 4(1):15. PubMed ID: 23706040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study.
    Brašić JR; Goodman JA; Nandi A; Russell DS; Jennings D; Barret O; Martin SD; Slifer K; Sedlak T; Mathur AK; Seibyl JP; Berry-Kravis EM; Wong DF; Budimirovic DB
    Brain Sci; 2022 Feb; 12(3):. PubMed ID: 35326270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study.
    Brašić JR; Nandi A; Russell DS; Jennings D; Barret O; Martin SD; Slifer K; Sedlak T; Seibyl JP; Wong DF; Budimirovic DB
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome.
    Brašić JR; Nandi A; Russell DS; Jennings D; Barret O; Mathur A; Slifer K; Sedlak T; Martin SD; Brinson Z; Vyas P; Seibyl JP; Berry-Kravis EM; Wong DF; Budimirovic DB
    Brain Sci; 2020 Nov; 10(12):. PubMed ID: 33255214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal PET studies of mGluR5 in FXS using an FMR1 knockout mouse model.
    Afshar S; Lule S; Yuan G; Qu X; Pan C; Whalen M; Brownell AL; Mody M
    Transl Neurosci; 2022 Jan; 13(1):80-92. PubMed ID: 35582646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward therapeutic potential for AFQ056 in Fragile X syndrome.
    Sourial M; Cheng C; Doering LC
    J Exp Pharmacol; 2013; 5():45-54. PubMed ID: 27186135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
    Jacquemont S; Curie A; des Portes V; Torrioli MG; Berry-Kravis E; Hagerman RJ; Ramos FJ; Cornish K; He Y; Paulding C; Neri G; Chen F; Hadjikhani N; Martinet D; Meyer J; Beckmann JS; Delange K; Brun A; Bussy G; Gasparini F; Hilse T; Floesser A; Branson J; Bilbe G; Johns D; Gomez-Mancilla B
    Sci Transl Med; 2011 Jan; 3(64):64ra1. PubMed ID: 21209411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mGluR5 Negative Modulators for Fragile X: Treatment Resistance and Persistence.
    Stoppel DC; McCamphill PK; Senter RK; Heynen AJ; Bear MF
    Front Psychiatry; 2021; 12():718953. PubMed ID: 34658956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.
    Fatemi SH; Folsom TD
    Schizophr Res; 2015 Sep; 167(1-3):42-56. PubMed ID: 25432637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.
    Deschwanden A; Karolewicz B; Feyissa AM; Treyer V; Ametamey SM; Johayem A; Burger C; Auberson YP; Sovago J; Stockmeier CA; Buck A; Hasler G
    Am J Psychiatry; 2011 Jul; 168(7):727-34. PubMed ID: 21498461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors.
    Nakamoto M; Nalavadi V; Epstein MP; Narayanan U; Bassell GJ; Warren ST
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15537-42. PubMed ID: 17881561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.
    Thomas AM; Bui N; Graham D; Perkins JR; Yuva-Paylor LA; Paylor R
    Behav Brain Res; 2011 Oct; 223(2):310-21. PubMed ID: 21571007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of mavoglurant and its potential for the treatment of fragile X syndrome.
    Gomez-Mancilla B; Berry-Kravis E; Hagerman R; von Raison F; Apostol G; Ufer M; Gasparini F; Jacquemont S
    Expert Opin Investig Drugs; 2014 Jan; 23(1):125-34. PubMed ID: 24251408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results.
    Youssef EA; Berry-Kravis E; Czech C; Hagerman RJ; Hessl D; Wong CY; Rabbia M; Deptula D; John A; Kinch R; Drewitt P; Lindemann L; Marcinowski M; Langland R; Horn C; Fontoura P; Santarelli L; Quiroz JA;
    Neuropsychopharmacology; 2018 Feb; 43(3):503-512. PubMed ID: 28816242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice.
    Vinueza Veloz MF; Buijsen RA; Willemsen R; Cupido A; Bosman LW; Koekkoek SK; Potters JW; Oostra BA; De Zeeuw CI
    Genes Brain Behav; 2012 Apr; 11(3):325-31. PubMed ID: 22257369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in fragile X: a model for autism and neurodegeneration.
    Hagerman RJ; Ono MY; Hagerman PJ
    Curr Opin Psychiatry; 2005 Sep; 18(5):490-6. PubMed ID: 16639106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabotropic glutamate receptor 5 responses dictate differentiation of neural progenitors to NMDA-responsive cells in fragile X syndrome.
    Achuta VS; Grym H; Putkonen N; Louhivuori V; Kärkkäinen V; Koistinaho J; Roybon L; Castrén ML
    Dev Neurobiol; 2017 Apr; 77(4):438-453. PubMed ID: 27411166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of fragile X syndrome in mice.
    Dölen G; Osterweil E; Rao BS; Smith GB; Auerbach BD; Chattarji S; Bear MF
    Neuron; 2007 Dec; 56(6):955-62. PubMed ID: 18093519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome.
    Thomas AM; Bui N; Perkins JR; Yuva-Paylor LA; Paylor R
    Psychopharmacology (Berl); 2012 Jan; 219(1):47-58. PubMed ID: 21656124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitro.
    Tabolacci E; Pirozzi F; Gomez-Mancilla B; Gasparini F; Neri G
    BMC Med Genet; 2012 Mar; 13():13. PubMed ID: 22397687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.